Coronary Artery Disease Reporting and Data System (CAD-RADS) was created to standardize reporting system for patients undergoing coronary CT angiography (CCTA) and to guide possible next steps in patient management.

CAD-RADS is the Coronary Artery Disease-Reporting and Data System. CAD-RADS is developed to standardize reporting of coronary CTA, to improve communication and to guide therapy.

“CAD-RADS: Coronary Artery Disease – Reporting and Data System.: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI).

Coronary Artery Disease Reporting and Data System (CAD-RADS) was created to standardize reporting system for patients undergoing coronary CT angiography (CCTA) and to guide possible next steps in patient management.

CAD-RADS is the Coronary Artery Disease-Reporting and Data System. CAD-RADS is developed to standardize reporting of coronary CTA, to improve communication and to guide therapy. The...

Coronary Artery Disease Reporting and Data System (CAD-RADS) was created to standardize reporting system for patients undergo-ing coronary CT angiography (CCTA) and to guide possible next steps in patient management.

Interactive calculator for standardized reporting of coronary CT angiography using the CAD-RADS ™ 2.0 system.

Jul 23, 2024 · The Coronary Artery Disease - Reporting and Data System (CAD-RADS) is a standardized method for reporting and communicating coronary CT angiography findings and serves as a clinical decision support tool to guide subsequent patient management.

Mar 30, 2023 · CAD-RADS has been validated and has gained wide acceptance in the cardiac imaging community. The new iteration of CAD-RADS carries on with classification based on maximum degree of stenosis, adding new modifiers for …

The goal of this updated 2022 CAD-RADS 2.0 is to improve the initial reporting system for CCTA by considering new technical developments in cardiac CT, including data from recent clinical trials and new clinical guidelines.